Avantax Advisory Services, Inc. Zai Lab LTD Transaction History
Avantax Advisory Services, Inc.
- $17.6 Billion
- Q2 2025
A detailed history of Avantax Advisory Services, Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 7,878 shares of ZLAB stock, worth $265,409. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,878
Previous 6,234
26.37%
Holding current value
$265,409
Previous $225,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ZLAB
# of Institutions
170Shares Held
38.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$203 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$187 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$135 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$74 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$53.5 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.3B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...